Plant Comparison
Horse Chestnut vs Corn Silk
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Horse Chestnut and Corn Silk: they share 5 indicated uses (arthritis / joint pain, cancer (anticancer research), inflammation (general), …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Horse Chestnut | Corn Silk | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 2/10 | 1/10 | Comparable evidence |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 2/10 | 1/10 | Comparable evidence |
| Skin irritation | 2/10 | 1/10 | Comparable evidence |
| Swelling / fluid retention | 7/10 | 1/10 | Stronger for Horse Chestnut |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The active mixture responsible for the venotonic and anti-oedematous effects; extracts are standardised to it. Escin is available as oral drages and a transdermal gel, with efficacy shown in chronic venous insufficiency and blunt-trauma injury.
Major antioxidant constituents of corn silk; maysin is the predominant flavonoid quantified in standardised extracts.
Contribute to antioxidant and anti-inflammatory activity.
Pharmacological Actions
Anti-oedematous and anti-inflammatory - escin reduces vascular permeability in inflamed tissue and exerts venotonic effects on veins
Anti-oedematous and anti-inflammatory - escin reduces vascular permeability in inflamed tissue and exerts venotonic effects on veins
Escin, the triterpene saponin of Aesculus hippocastanum, induces apoptosis and cell-cycle arrest and chemosensitizes breast, hepatocellular, lung and pancreatic cancer cells (preclinical, including in vivo xenograft models).
Traditional & Indicated Uses
inferred from anti-inflammatory action
Escin shows antiproliferative and pro-apoptotic activity and enhances chemotherapy/immunotherapy efficacy in breast (MCF-7), hepatocellular, lung and pancreatic cancer models; it modulates NF-kappaB, p53, p38 MAPK/ERK and PD-L1 (preclinical).
Relief of haemorrhoid symptoms (venotonic)
inferred from anti-inflammatory action
Chronic venous insufficiency - reduces leg pain, swelling (oedema), heaviness and itching; supports varicose veins
inferred from anti-inflammatory action
Chronic venous insufficiency - reduces leg pain, swelling (oedema), heaviness and itching; supports varicose veins
inferred from anti-inflammatory action
inferred from anticancer action
Soothing demulcent for urinary-tract irritation and mild urinary infections; supports kidney function
inferred from anti-inflammatory action
inferred from demulcent action
Diuretic - increases urine output to support the urinary tract and mild fluid retention/swelling; in conscious rats the aqueous extract is diuretic and kaliuretic and modifies glomerular filtration and potassium excretion
inferred from diuretic action
Diuretic - increases urine output to support the urinary tract and mild fluid retention/swelling; in conscious rats the aqueous extract is diuretic and kaliuretic and modifies glomerular filtration and potassium excretion; Soothing demulcent for urinary-tract irritation and mild urinary infections; supports kidney function
Safety, Cautions & Contraindications
Use only standardised, processed seed extract. Raw conkers, leaves and bark contain toxic esculin and can cause poisoning - never eat raw horse chestnut.
May increase bleeding risk, so use caution with anticoagulant/antiplatelet medicines; use caution in kidney disease and avoid in pregnancy and breastfeeding.
As a diuretic it should be taken with plenty of fluids; use caution alongside prescription diuretics or medicines that affect potassium.
May lower blood sugar and blood pressure, so use caution with antidiabetic or antihypertensive medication; avoid concentrated medicinal doses in pregnancy - a high-dose standardised extract increased pre-implantation losses in pregnant rats (no fetal malformations were seen).
External Ids
Botanical Description
Large deciduous tree, to 25-30 m, with a broad domed crown and stout, upward-arching branches. The leaves are opposite and palmately compound, with five to seven large, obovate, toothed leaflets radiating from a long stalk. In spring the tree bears large, showy, upright pyramidal flower spikes ('candles') of white flowers marked with yellow or pink at the base. The glossy brown seeds ('conkers') develop inside a spiky green husk and fall in autumn.[1]
Tall, robust annual grass with broad, strap-like leaves and a stout, jointed stem. Male flowers form a terminal tassel; female flowers develop on the ear (cob), each floret bearing a single long, silky style and stigma ('corn silk') that protrudes from the husk to catch pollen.[11]
Habitat
Native to the Balkan Peninsula, and widely planted and naturalised as an ornamental and avenue tree across temperate Europe, North America and elsewhere.[1]
Cultivated worldwide as a major cereal food crop in warm-temperate to tropical climates on fertile, well-drained soils; not found wild, having been domesticated from a wild grass ancestor (teosinte) in Mesoamerica.[11]
Harvesting
The silky stigmas and styles are collected from the ears in mid- to late summer, just before or as pollination occurs, while still fresh and pale, then dried quickly to preserve colour and flavonoid content.[11]
Traditional Uses
Horse chestnut seed has a long folk history as a remedy for varicose veins, haemorrhoids and 'heavy legs', and was also used topically for rheumatic pain and bruising. Modern use is almost exclusively as a standardised seed extract for chronic venous insufficiency, confirming this traditional venous-support reputation.[1]
Corn silk has a long traditional use across Chinese, Native American and European folk medicine as a gentle diuretic and soothing demulcent for urinary tract complaints, mild fluid retention and kidney support.[11]
Preparations
Dried corn silk infused in hot water as a traditional diuretic and urinary-support tea.
Dosage
Clinical studies commonly use extracts standardised to around 100-150 mg escin daily, in divided doses. Educational reference only, not a prescription.
The EU herbal monograph gives semi-solid dosage forms containing the equivalent of 0.4% triterpene glycosides calculated as protoaescigenin (or, depending on the preparation, 0.85-20% herbal preparation), applied as a thin layer to the affected area 1-3 times daily, in adults and elderly. Educational reference only, not a prescription.
Not documented
References
Drug Class Interactions
Not documented
Lookalikes Review
References & Sources
- Idris, S. and Mishra, A. and Khushtar, M (2020) 'Phytochemical, ethnomedicinal and pharmacological applications of escin from Aesculus hippocastanum L. towards future medicine', Journal of Basic and Clinical Physiology and Pharmacology, 31(5). doi:10.1515/jbcpp-2019-0115 Meta-analysis / review
https://doi.org/10.1515/jbcpp-2019-0115 - Penaranda Figueredo, F.A. and Vicente, J. and Barquero, A.A. and Bueno, C.A (2024) 'Aesculus hippocastanum extract and the main bioactive constituent beta-escin as antivirals agents against coronaviruses, including SARS-CoV-2', Scientific Reports, 14(1), pp. 6418. doi:10.1038/s41598-024-56759-y Preclinical
https://doi.org/10.1038/s41598-024-56759-y - Idris, S. and Mishra, A. and Khushtar, M (2023) 'Phytochemical Estimation and Therapeutic Amelioration of Aesculus hippocastanum L. Seeds Ethanolic Extract in Gastric Ulcer in Rats Possibly by Inhibiting Prostaglandin Synthesis', Chinese Journal of Integrative Medicine, 29(9), pp. 818-824. doi:10.1007/s11655-023-3734-9 Preclinical
https://doi.org/10.1007/s11655-023-3734-9 - Quarta, S. and Santarpino, G. and Carluccio, M.A. and Calabriso, N. and Scoditti, E. and Siculella, L. and Damiano, F. and Maffia, M. and Verri, T. and De Caterina, R. and Massaro, M (2022) 'Analysis of the Anti-Inflammatory and Anti-Osteoarthritic Potential of Flonat Fast, a Combination of Plant Extracts, Bromelain and Escin (Aesculus hippocastanum), Evaluated in In Vitro Models of Inflammation Relevant to Osteoarthritis', Pharmaceuticals, 15(10), pp. 1263. doi:10.3390/ph15101263 Preclinical
https://doi.org/10.3390/ph15101263 - Owczarek, A. and Kolodziejczyk-Czepas, J. and Wozniak-Serwata, J. and Magiera, A. and Kobiela, N. and Wasowicz, K. and Olszewska, M.A (2021) 'Potential Activity Mechanisms of Aesculus hippocastanum Bark: Antioxidant Effects in Chemical and Biological In Vitro Models', Antioxidants, 10(7), pp. 995. doi:10.3390/antiox10070995 Preclinical
https://doi.org/10.3390/antiox10070995 - Cheong, D.H.J., Arfuso, F., Sethi, G., Wang, L., Hui, K.M., Kumar, A.P. and Tran, T (2018) 'Molecular targets and anti-cancer potential of escin', Cancer Letters. doi:10.1016/j.canlet.2018.02.027 Preclinical
https://doi.org/10.1016/j.canlet.2018.02.027 - Pittler, M.H. and Ernst, E (2012) 'Horse chestnut seed extract for chronic venous insufficiency', Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD003230.pub4 Meta-analysis / review
https://doi.org/10.1002/14651858.CD003230.pub4 - Gallelli, L (2019) 'Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties', Drug Design, Development and Therapy, pp. 3425--3437. doi:10.2147/DDDT.S207720 Preclinical
https://doi.org/10.2147/DDDT.S207720 - Wu, X.J., Zhang, M.L., Cui, X.Y., Gao, F., He, Q., Li, X.J., Zhang, J.W., Fawcett, J.P. and Gu, J.K (2011) 'Comparative pharmacokinetics and bioavailability of escin Ia and isoescin Ia after administration of escin and of pure escin Ia and isoescin Ia in rat', Journal of Ethnopharmacology, 139(1), pp. 201--206. doi:10.1016/j.jep.2011.11.003 Preclinical
https://doi.org/10.1016/j.jep.2011.11.003 - European Medicines Agency (HMPC) (2023) 'European Union herbal monograph on Aesculus hippocastanum L., semen, Revision 1'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/european-union-herbal-monograph-aesculus-hippocastanum-l-semen-final-revision-1_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/european-union-herbal-monograph-aesculus-hippocastanum-l-semen-final-revision-1_en.pdf - Cheong, D.H.J., Arfuso, F., Sethi, G., Wang, L., Hui, K.M., Kumar, A.P. and Tran, T (2018) 'Molecular targets and anti-cancer potential of escin', Cancer Letters, pp. 1--8. doi:10.1016/j.canlet.2018.02.027 Preclinical
https://doi.org/10.1016/j.canlet.2018.02.027 - Mazrouei, R. and Raeisi, E. and Lemoigne, Y. and Heidarian, E (2019) 'Activation of p53 Gene Expression and Synergistic Antiproliferative Effects of 5-Fluorouracil and beta-escin on MCF7 Cells', Journal of Medical Signals and Sensors, 9(3), pp. 196-203. doi:10.4103/jmss.JMSS_44_18 Preclinical
https://doi.org/10.4103/jmss.JMSS_44_18 - Yuan, Y. and Wang, P. and Chen, S. and Cao, Z. and Ojha, S.C. and Sun, C. and Wang, G. and Wang, Z. and Gu, J. and Kang, J. and Xue, X (2025) 'Escin inhibits PD-L1 expression by suppressing the p38 MAPK/ERK signalling pathways and synergistically enhances PD-1 inhibitor efficacy in hepatocellular carcinoma', Phytomedicine, 149, pp. 157532. doi:10.1016/j.phymed.2025.157532 Preclinical
https://doi.org/10.1016/j.phymed.2025.157532 - Hussain, Y. and Singh, J. and Meena, A. and Sinha, R.A. and Luqman, S (2023) 'Escin enhanced the efficacy of sorafenib by autophagy-mediated apoptosis in lung cancer cells', Phytotherapy Research, 37(10), pp. 4819-4837. doi:10.1002/ptr.7948 Preclinical
https://doi.org/10.1002/ptr.7948 - Rimmon, A. and Vexler, A. and Berkovich, L. and Earon, G. and Ron, I. and Lev-Ari, S (2013) 'Escin Chemosensitizes Human Pancreatic Cancer Cells and Inhibits the Nuclear Factor-kappaB Signaling Pathway', Biochemistry Research International, 2013, pp. 251752. doi:10.1155/2013/251752 Preclinical
https://doi.org/10.1155/2013/251752 - Domanski, D., Zegrocka-Stendel, O., Perzanowska, A., Dutkiewicz, M., Kowalewska, M., Grabowska, I., Maciejko, D., Fogtman, A., Dadlez, M. and Koziak, K (2016) 'Molecular Mechanism for Cellular Response to beta-Escin and Its Therapeutic Implications', PLoS One, 11(10). doi:10.1371/journal.pone.0164365 Preclinical
https://doi.org/10.1371/journal.pone.0164365 - Gloviczki, M.L., Kakkos, S.K., Urbanek, T., Chuback, J. and Nicolaides, A (2025) 'The role of venoactive compounds in the treatment of chronic venous disease', Journal of Vascular Surgery: Venous and Lymphatic Disorders, 13(5). doi:10.1016/j.jvsv.2025.102258 Preclinical
https://doi.org/10.1016/j.jvsv.2025.102258 - Santiago, F.R., Grillo, L., Amore, M., Carmelino, C., Trejo, J.M.R. and Ulloa, J.H (2026) 'Venoactive drugs in the management of chronic venous disease: A critical appraisal of the evidence and comparison with international guidelines', Vascular Pharmacology. doi:10.1016/j.vph.2026.107614 Preclinical
https://doi.org/10.1016/j.vph.2026.107614 - Pittler, M.H. and Ernst, E (2006) 'Horse chestnut seed extract for chronic venous insufficiency', Cochrane Database of Systematic Reviews, 2006(1), pp. CD003230. doi:10.1002/14651858.CD003230.pub3 Meta-analysis / review
https://doi.org/10.1002/14651858.CD003230.pub3
- Zhang, Y., Wu, L., Ma, Z., Cheng, J. and Liu, J (2018) 'Corn silk (Zea mays L.), a source of natural antioxidants with alpha-amylase, alpha-glucosidase, advanced glycation and diabetic nephropathy inhibitory activities', Biomedicine & Pharmacotherapy, 110, pp. 510-517. doi:10.1016/j.biopha.2018.11.126 Preclinical
https://doi.org/10.1016/j.biopha.2018.11.126 - Wang, Y. and others (2023) 'Corn Silk Flavonoids Ameliorate Hyperuricemia via PI3K/AKT/NF-kappaB Pathway', Journal of Agricultural and Food Chemistry, 71(26), pp. 9968-9979. doi:10.1021/acs.jafc.3c03422 Preclinical
https://doi.org/10.1021/acs.jafc.3c03422 - Habtemariam, S (1998) 'Extract of corn silk (stigma of Zea mays) inhibits the tumour necrosis factor-alpha- and bacterial lipopolysaccharide-induced cell adhesion and ICAM-1 expression', Planta Medica, 64(4), pp. 314-318. doi:10.1055/s-2006-957441 Preclinical
https://doi.org/10.1055/s-2006-957441 - Chen, M.Y., Wu, J.M. and others (2025) 'Unlocking Corn Silk's Potential: Bioactive Compounds Targeting Age-Related Diseases', Molecular Nutrition & Food Research, 69(10), pp. e70117. doi:10.1002/mnfr.70117 Meta-analysis / review
https://doi.org/10.1002/mnfr.70117 - Li, Y. and others (2023) 'Diterpenoid and phenolic constituents from corn silk (Zea mays) with PTP1B inhibitory activity', Natural Product Research, 37(24), pp. 4189-4196. doi:10.1080/14786419.2023.2265038 Preclinical
https://doi.org/10.1080/14786419.2023.2265038 - Wang, B. and others (2019) 'Corn Silk (Zea mays) Induced Apoptosis in Human Breast Cancer (MCF-7) Cells via the ROS-Mediated Mitochondrial Pathway', Oxidative Medicine and Cellular Longevity, 2019, pp. 9789241. doi:10.1155/2019/9789241 Preclinical
https://doi.org/10.1155/2019/9789241 - Guo, J. and others (2024) 'Extraction, purification, structural characteristics, and pharmacological activities of the polysaccharides from corn silk: A review', International Journal of Biological Macromolecules, 274, pp. 133433. doi:10.1016/j.ijbiomac.2024.133433 Meta-analysis / review
https://doi.org/10.1016/j.ijbiomac.2024.133433 - Li, X. and others (2025) 'Ultrasound-assisted extraction of anti-inflammatory actives from corn silk (Zea mays L.): Process optimization, machine learning screening, and interaction mechanisms', Ultrasonics Sonochemistry, 118, pp. 107420. doi:10.1016/j.ultsonch.2025.107420 Preclinical
https://doi.org/10.1016/j.ultsonch.2025.107420 - Wang, Y. and others (2024) 'An Umbrella Insight into the Phytochemistry Features and Biological Activities of Corn Silk: A Narrative Review', Molecules, 29(4), pp. 891. doi:10.3390/molecules29040891 Meta-analysis / review
https://doi.org/10.3390/molecules29040891 - Zhang, W. and others (2023) 'Acidic polysaccharide from corn silk: Structural & conformational properties and hepatoprotective activity', International Journal of Biological Macromolecules, 237, pp. 123851. doi:10.1016/j.ijbiomac.2023.123851 Preclinical
https://doi.org/10.1016/j.ijbiomac.2023.123851 - Hasanudin, K., Hashim, P. and Mustafa, S (2012) 'Corn Silk (Stigma Maydis) in Healthcare: A Phytochemical and Pharmacological Review', Molecules. doi:10.3390/molecules171112937 Traditional / reference
https://doi.org/10.3390/molecules171112937 - Caixeta, G.A.B. and dos Santos Reis, D. and Soares, K.I. and de Brito Ramos, I. and Mendes, G.H.L. and others (2025) 'Toxicological Assessment of a Standardized Dry Extract of Zea mays L. (Poaceae) Stigmas During Gestation: Effects on Maternal Parameters and Fetal Outcomes in Wistar Rats', Birth Defects Research, 117(9). doi:10.1002/bdr2.2526 Traditional / reference
https://doi.org/10.1002/bdr2.2526 - Velazquez, D.V.O. and Xavier, H.S. and Batista, J.E.M. and de Castro-Chaves, C (2005) 'Zea mays L. extracts modify glomerular function and potassium urinary excretion in conscious rats', Phytomedicine, 12(5), pp. 363--369. doi:10.1016/j.phymed.2003.12.010 Traditional / reference
https://doi.org/10.1016/j.phymed.2003.12.010
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.